Cerebral Vascular Stent Market Research Report Information by Product (Tantalum, Stainless Steel, Nitinol), End User (Hospital and Ambulatory Surgery Centers) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Demand and Supply

5.3.3. Regional Impact

5.3.4. Impact on Market Growth

6. GLOBAL CEREBRAL VASCULAR STENTMARKET, BY TYPE

6.1. Overview

6.2. Tantalum

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.3. Stainless steel

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.4. Nitinol

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7. GLOBAL CEREBRAL VASCULAR STENT MARKET, BY END USER

7.1. Overview

7.2. Hospitals

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.3. Ambulatory Surgery Centers

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8. GLOBAL CEREBRAL VASCULAR STENTMARKET, BY REGION

8.1. Overview

8.2. North America

8.2.1. US

8.2.2. Canada

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. Italy

8.3.4. Spain

8.3.5. UK

8.3.6. Rest of Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Rest of the World

8.5.1. Middle East

8.5.2. Africa

8.5.3. Latin America

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Cerebral Vascular StentMarket

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Cerebral Vascular StentMarket

9.7. Key Developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger &Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2020

9.8.2. Major Players R&D Expenditure, 2020

10. COMPANY PROFILES

10.1. Stryker Corporation

10.1.1. Company Overview

10.1.2. Products and Services Offered

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Boston Scientific Corporation

10.2.1. Company Overview

10.2.2. Products and ServicesOffered

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Johnson & Johnson Services, Inc.

10.3.1. Company Overview

10.3.2. Products and Services Offered

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Terumo Corporation

10.4.1. Company Overview

10.4.2. Products and Services Offered

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Cook Medical

10.5.1. Company Overview

10.5.2. Products and Services Offered

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Penumbra, Inc.

10.6.1. Company Overview

10.6.2. Products and Services Offered

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Medtronic plc

10.7.1. Company Overview

10.7.2. Products and Services Offered

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. J-Pillow

10.8.1. Company Overview

10.8.2. Products and Services Offered

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Acandis GmbH

10.9.1. Company Overview

10.9.2. Products and Services Offered

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Mediflow

10.10.1. Company Overview

10.10.2. Products and Services Offered

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Phenox GmbH

10.11.1. Company Overview

10.11.2. Products and Services Offered

10.11.3. Financial Overview

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. PharMeDoc

10.12.1. Company Overview

10.12.2. Products and Services Offered

10.12.3. Financial Overview

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. MicroPort Scientific Corporation

10.13.1. Company Overview

10.13.2. Products and Services Offered

10.13.3. Financial Overview

10.13.4. Key Developments

10.13.5. SWOT Analysis

10.13.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL CEREBRAL VASCULAR STENTMARKET SYNOPSIS, 2018–2027

TABLE 2 GLOBAL CEREBRAL VASCULAR STENTMARKET ESTIMATES &FORECAST, 2018–2027(USD MILLION)

TABLE 3 GLOBAL CEREBRAL VASCULAR STENTMARKET, BYTYPE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 5 NORTH AMERICA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 6 NORTH AMERICA: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 7 US: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 8 US: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 9 CANADA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 10 CANADA: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 11 EUROPE: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 EUROPE: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 13 GERMANY: CEREBRAL VASCULAR STENT MARKET, BY TYPE,,2018–2027 (USD MILLION)

TABLE 14 GERMANY: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 15 UK: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 16 UK: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 17 FRANCE: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 18 FRANCE: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 19 ITALY: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 20 ITALY: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 21 SPAIN: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 22 SPAIN: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 23 REST OF EUROPE: CEREBRAL VASCULAR STENT MARKET, BY TYPE,,2018–2027 (USD MILLION)

TABLE 24 REST OF EUROPE: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 27 INDIA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 28 INDIA: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 29 CHINA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 30 CHINA: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 31 JAPAN: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 32 JAPAN: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 33 SOUTH KOREACEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 34 SOUTH KOREA: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 35 AUSTRALIA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 36 AUSTRALIA: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 37 REST OF ASIA-PACIFIC: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 38 REST OF ASIA-PACIFIC: CEREBRAL VASCULAR STENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 39 REST OF THE WORLD: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 40 REST OF THE WORLD: CEREBRAL VASCULAR STENT MARKET, END USER, 2018–2027 (USD MILLION)

TABLE 41 MIDDLE EAST: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 42 MIDDLE EAST: CEREBRAL VASCULAR STENT MARKET, END USER, 2018–2027 (USD MILLION)

TABLE 43 AFRICA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 44 AFRICA: CEREBRAL VASCULAR STENT MARKET, END USER, 2018–2027 (USD MILLION)

TABLE 45 LATIN AMERICA: CEREBRAL VASCULAR STENT MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 46 LATIN AMERICA: CEREBRAL VASCULAR STENT MARKET, END USER, 2018–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CEREBRAL VASCULAR STENTMARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CEREBRAL VASCULAR STENTMARKET

FIGURE 4 GLOBAL CEREBRAL VASCULAR STENTMARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL CEREBRAL VASCULAR STENT MARKET SHARE, BY END USER, 2020 (%)

FIGURE 6 GLOBAL CEREBRAL VASCULAR STENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 NORTH AMERICA: CEREBRAL VASCULAR STENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 EUROPE: CEREBRAL VASCULAR STENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 ASIA-PACIFIC: CEREBRAL VASCULAR STENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 REST OF THE WORLD: CEREBRAL VASCULAR STENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 GLOBAL CEREBRAL VASCULAR STENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 12 STRYKER CORPORATION: KEY FINANCIALS

FIGURE 13 STRYKER CORPORATION: SEGMENTAL REVENUE

FIGURE 14 STRYKER CORPORATION: REGIONAL REVENUE

FIGURE 15 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS

FIGURE 16 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

FIGURE 17 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE

FIGURE 18 JOHNSON & JOHNSON SERVICES, INC.: KEY FINANCIALS

FIGURE 19 JOHNSON & JOHNSON SERVICES, INC.: SEGMENTAL REVENUE

FIGURE 20 JOHNSON & JOHNSON SERVICES, INC.: REGIONAL REVENUE

FIGURE 21 TERUMO CORPORATION: KEY FINANCIALS

FIGURE 22 TERUMO CORPORATION: SEGMENTAL REVENUE

FIGURE 23 TERUMO CORPORATION: REGIONAL REVENUE

FIGURE 24 COOK MEDICAL: KEY FINANCIALS

FIGURE 25 COOK MEDICAL: SEGMENTAL REVENUE

FIGURE 26 COOK MEDICAL: REGIONAL REVENUE

FIGURE 27 PENUMBRA, INC.: KEY FINANCIALS

FIGURE 28 PENUMBRA, INC.: SEGMENTAL REVENUE

FIGURE 29 PENUMBRA, INC.: REGIONAL REVENUE

FIGURE 30 MEDTRONIC PLC: KEY FINANCIALS

FIGURE 31 MEDTRONIC PLC: SEGMENTAL REVENUE

FIGURE 32 MEDTRONIC PLC: REGIONAL REVENUE

FIGURE 33 ACANDIS GMBH: KEY FINANCIALS

FIGURE 34 ACANDIS GMBH: SEGMENTAL REVENUE

FIGURE 35 ACANDIS GMBH: REGIONAL REVENUE

FIGURE 36 PHENOX GMBH: KEY FINANCIALS

FIGURE 37 PHENOX GMBH: SEGMENTAL REVENUE

FIGURE 38 PHENOX GMBH: REGIONAL REVENUE

FIGURE 39 MICROPORT SCIENTIFIC CORPORATIONKEY FINANCIALS

FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

FIGURE 41 MICROPORT SCIENTIFIC CORPORATION: REGIONAL REVENUE